These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23190096)

  • 1. Critical role for drug delivery in the development of new ophthalmic treatments.
    Sheardown H
    Future Med Chem; 2012 Nov; 4(17):2123-5. PubMed ID: 23190096
    [No Abstract]   [Full Text] [Related]  

  • 2. Are contact lenses the solution for effective ophthalmic drug delivery?
    Bengani L; Chauhan A
    Future Med Chem; 2012 Nov; 4(17):2141-3. PubMed ID: 23190101
    [No Abstract]   [Full Text] [Related]  

  • 3. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
    Jung HJ; Chauhan A
    Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact lenses for drug delivery.
    Ciolino JB; Dohlman CH; Kohane DS
    Semin Ophthalmol; 2009; 24(3):156-60. PubMed ID: 19437351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
    Shen J; Lu GW; Hughes P
    Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the posterior segment of the eye.
    Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
    Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in ocular drug delivery.
    Weiner AL; Gilger BC
    Vet Ophthalmol; 2010 Nov; 13(6):395-406. PubMed ID: 21182726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmic drug delivery: development and regulatory considerations.
    Novack GD
    Clin Pharmacol Ther; 2009 May; 85(5):539-43. PubMed ID: 19225448
    [No Abstract]   [Full Text] [Related]  

  • 9. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular drug delivery-eye on innovation.
    Rupenthal ID; O'Rourke M
    Drug Deliv Transl Res; 2016 Dec; 6(6):631-633. PubMed ID: 27766597
    [No Abstract]   [Full Text] [Related]  

  • 13. Iontophoresis: a non-invasive ocular drug delivery.
    Eljarrat-Binstock E; Domb AJ
    J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of betamethasone from vitamin E-loaded silicone-based soft contact lenses.
    Rad MS; Sajadi Tabassi SA; Moghadam MH; Mohajeri SA
    Pharm Dev Technol; 2016 Nov; 21(7):894-899. PubMed ID: 26334597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery systems for the eye.
    Kearns VR; Williams RL
    Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-Based Design of Multi-Layered Ophthalmic Lenses for Controlled Drug Release.
    Pimenta AF; Serro AP; Paradiso P; Saramago B; Colaço R
    PLoS One; 2016; 11(12):e0167728. PubMed ID: 27936138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in sustained-release drug delivery system for treatment of posterior segment eye diseases].
    Sun SM; Cheng LY
    Zhonghua Yan Ke Za Zhi; 2013 Sep; 49(9):847-50. PubMed ID: 24330936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological availability of ophthalmic preparations. 2. Ophthalmic therapeutic systems].
    Masteiková R; Chalupová Z; Savickas A
    Ceska Slov Farm; 2004 Sep; 53(5):211-8. PubMed ID: 15506702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of ketotifen fumarate-loaded silicone hydrogel contact lenses for ocular drug delivery.
    Xu J; Li X; Sun F
    Drug Deliv; 2011 Feb; 18(2):150-8. PubMed ID: 21043996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interview with Paul Ashton: sustained-release drug delivery to the eye.
    Ashton P
    Ther Deliv; 2013 Mar; 4(3):297-9. PubMed ID: 23442076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.